Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
4
×
deals
4
×
life sciences
national blog main
national top stories
startups
4
×
san francisco blog main
boston
glaxosmithkline
new york blog main
new york top stories
san francisco top stories
vc
acetylon pharmaceuticals
allosteric
alnylam pharmaceuticals
ambys medicines
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
beijing
beta-thalassemia
brace pharma
brii bio
brii biosciences
cell therapy
china
cleva pharma
clinical trials
constellation pharmaceuticals
dacogen
decitabine
dna
drug discovery
dupilumab
epigenetics
epizyme
What
medicines
4
×
new
adds
biotech
disease
startup
therapeutics
address
ago
aiming
aims
alliance
allosteric
ambys
approach
areas
based
big
biosciences
bio’s
brii
called
clinic
control
deadly
deal
debuted
debuts
developing
diseases
drug
drugs
earlier
elusive
epigenetic
epigenetics
field
flagship’s
formed
future
Language
unset
Current search:
medicines
×
biotech
×
deals
×
startups
×
" boston top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
